Careful Scrutiny of the Evidence for Drug-Drug Interactions in Clinical Decision Support Systems Is Necessary

被引：3
|
作者：
Horn, John R. [1 ,2 ]
Hansten, Philip D. [1 ]
机构：
[1] Univ Washington, Sch Pharm, Seattle, WA 98195 USA
[2] Univ Washington, UW Med Hlth Syst, Seattle, WA 98195 USA
来源：
JOURNAL OF MANAGED CARE PHARMACY | 2011年 / 17卷 / 09期
关键词：
D O I：
10.18553/jmcp.2011.17.9.713
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：713 / 713
页数：1
相关论文
共 50 条
  • [21] Drug-drug interactions in clinical practice
    Depont, Fanny
    Vargas, Frederic
    Dutronc, Herve
    Giauque, Emmanuelle
    Ragnaud, Jean-Marie
    Galperine, Tatiana
    Abouelfath, Abdelilah
    Valentino, Ruddy
    Dupon, Michel
    Hebert, Guillaume
    Moore, Nicholas
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (11) : 1227 - 1233
  • [22] Coordinated use of Health Level 7 standards to support clinical decision support: Case study with shared decision making and drug-drug interactions
    Thiess, Henrik
    Del Fiol, Guilherme
    Malone, Daniel C.
    Cornia, Ryan
    Sibilla, Max
    Rhodes, Bryn
    Boyce, Richard D.
    Kawamoto, Kensaku
    Reese, Thomas
    INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS, 2022, 162
  • [23] Criteria for assessing high-priority drug-drug interactions for clinical decision support in electronic health records
    Phansalkar, Shobha
    Desai, Amrita
    Choksi, Anish
    Yoshida, Eileen
    Doole, John
    Czochanski, Melissa
    Tucker, Alisha D.
    Middleton, Blackford
    Bell, Douglas
    Bates, David W.
    BMC MEDICAL INFORMATICS AND DECISION MAKING, 2013, 13
  • [24] Criteria for assessing high-priority drug-drug interactions for clinical decision support in electronic health records
    Shobha Phansalkar
    Amrita Desai
    Anish Choksi
    Eileen Yoshida
    John Doole
    Melissa Czochanski
    Alisha D Tucker
    Blackford Middleton
    Douglas Bell
    David W Bates
    BMC Medical Informatics and Decision Making, 13
  • [25] Recommendations to improve the usability of drug-drug interaction clinical decision support alerts
    Payne, Thomas H.
    Hines, Lisa E.
    Chan, Raymond C.
    Hartman, Seth
    Kapusnik-Uner, Joan
    Russ, Alissa L.
    Chaffee, Bruce W.
    Hartman, Christian
    Tamis, Victoria
    Galbreth, Brian
    Glassman, Peter A.
    Phansalkar, Shobha
    van der Sijs, Heleen
    Gephart, Sheila M.
    Mann, Gordon
    Strasberg, Howard R.
    Grizzle, Amy J.
    Brown, Mary
    Kuperman, Gilad J.
    Steiner, Chris
    Sullins, Amanda
    Ryan, Hugh
    Wittie, Michael A.
    Malone, Daniel C.
    JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2015, 22 (06) : 1243 - 1250
  • [26] Customizing clinical decision support to prevent excessive drug-drug interaction alerts
    Horn, John R.
    Hansten, Philip D.
    Osborn, Jacqueline D.
    Wareham, Pamela
    Somani, Shabir
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2011, 68 (08) : 662 - 664
  • [27] Integrating Mechanistic Information to Predict Drug-Drug Interactions and Associated Relevance for Decision Support
    Noor, Adeeb
    2022 IEEE INTERNATIONAL IOT, ELECTRONICS AND MECHATRONICS CONFERENCE (IEMTRONICS), 2022, : 1 - 4
  • [28] THE SFINX/PHARAO COMPUTERIZED DECISION SUPPORT SYSTEM (CDSS) ON DRUG-DRUG INTERACTIONS AND PHARMACODYNAMICS
    Bottiger, Y.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : E161 - E161
  • [29] Phytocannabinoid drug-drug interactions and their clinical implications
    Silva, Daniela Amaral
    Pate, David W.
    Clark, Robert D.
    Davies, Neal M.
    El-Kadi, Ayman O. S.
    Lobenberg, Raimar
    PHARMACOLOGY & THERAPEUTICS, 2020, 215
  • [30] CLINICAL RELEVANCE OF DRUG-DRUG INTERACTIONS WITH DAROLUTAMIDE
    Floyd, Rebecca
    Sutton, Jennifer
    Olivier, Kara
    Zurth, Christian
    Smith, Matthew R.
    Shore, Neal
    ONCOLOGY NURSING FORUM, 2020, 47 (02)
12345